Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges

A Cano, P Turowski, M Ettcheto, JT Duskey… - Journal of …, 2021 - Springer
Increasing life expectancy has led to an aging population, which has consequently
increased the prevalence of dementia. Alzheimer's disease (AD), the most common form of …

Nanomedicine for the treatment of Alzheimer's disease

B Formicola, A Cox, R Dal Magro… - Journal of biomedical …, 2019 - ingentaconnect.com
Alzheimer's disease affects millions of people worldwide and this figure is continuously
increasing. Currently, there is no resolutive cure for this disorder, but a valid contribution …

Advances in alzheimer's diagnosis and therapy: The implications of nanotechnology

MJ Hajipour, MR Santoso, F Rezaee, H Aghaverdi… - Trends in …, 2017 - cell.com
Alzheimer's disease (AD) is a type of dementia that causes major issues for patients'
memory, thinking, and behavior. Despite efforts to advance AD diagnostic and therapeutic …

Nanomedicine: A Promising way to manage Alzheimer's disease

NH Khan, M Mir, EE Ngowi, U Zafar… - … in Bioengineering and …, 2021 - frontiersin.org
Alzheimer's disease (AD) is a devastating disease of the aging population characterized by
the progressive and slow brain decay due to the formation of extracellular plaques in the …

Nanomaterials for the treatment and diagnosis of Alzheimer's disease: an overview

M Bilal, M Barani, F Sabir, A Rahdar, GZ Kyzas - NanoImpact, 2020 - Elsevier
Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues

D Brambilla, B Le Droumaguet, J Nicolas… - … , Biology and Medicine, 2011 - Elsevier
Alzheimer's disease (AD) represents the most common form of dementia worldwide,
affecting more than 35 million people. Advances in nanotechnology are beginning to exert a …

Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents

A Nazem, GA Mansoori - Journal of Alzheimer's disease, 2008 - content.iospress.com
A century of research has passed since the discovery and definition of Alzheimer's disease
(AD), the primary common dementing disorder worldwide. However, AD lacks definite …

Nanomedicine in the management of Alzheimer's disease: State-of-the-art

SN Mir Najib Ullah, O Afzal, ASA Altamimi, H Ather… - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) is a deadly, progressive, and irreversible brain condition that
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …

Nanomedicine for the treatment of Alzheimer's disease

M Gregori, M Masserini, S Mancini - Nanomedicine, 2015 - Taylor & Francis
Alzheimer's disease affects more than 35 million people worldwide and this number is
presumed to double by the year 2050. Currently, there is no efficient therapy for this disorder …

Nanotechnology for Alzheimer disease

J Leszek, G Md Ashraf, WH Tse, J Zhang… - Current Alzheimer …, 2017 - ingentaconnect.com
Background: Alzheimer disease (AD) typically affects behavior, memory and thinking. The
change in brain have been reported to begin approx. 10-20 years before the appearance of …